Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H1TL
|
|||
| Former ID |
DCL000676
|
|||
| Drug Name |
ABT-874
|
|||
| Indication | Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0; ICD-9: 696] | Phase 3 | [1] | |
| Rheumatoid arthritis [ICD-11: FA20] | Phase 1 | [1] | ||
| Crohn disease [ICD-11: DD70; ICD-10: K50, K50.9; ICD-9: 555] | Discontinued in Phase 2 | [1] | ||
| Company |
Abbott; Astra Zeneca
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96. | |||
| REF 2 | Briakinumab for the treatment of plaque psoriasis.BioDrugs.2012 Feb 1;26(1):9-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.